PharmaShots | Incisive News in 3 Shots

Subscribe Now

Marinus

Marinus’ Ztalmy (ganaxolone) Receives EC’s Approval for Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency Disorder

Marinus’ Ztalmy (ganaxolone) Receives EC’s Approval for Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficienc...

July 31, 2023

Marinus Receives the EMA’s CHMP Positive Opinion of Ztalmy (ganaxolone) for the Adjunctive Treatment of Seizures Associated with CDKL5 Deficiency Disorder

Marinus Receives the EMA’s CHMP Positive Opinion of Ztalmy (ganaxolone) for the Adjunctive Treatment of Seizures Associated with C...

May 31, 2023

Insights+: The US FDA New Drug Approvals in March 2022

Insights+: The US FDA New Drug Approvals in March 2022

April 21, 2022

Marinus’ Ztalmy (ganaxolone) Receives the US FDA’s Approval for the Treatment of CDKL5 Deficiency Disorder

Marinus’ Ztalmy (ganaxolone) Receives the US FDA’s Approval for the Treatment of CDKL5 Deficiency Disorder

March 21, 2022

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

August 6, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us